Literature DB >> 23768340

Camel milk lactoferrin reduces the proliferation of colorectal cancer cells and exerts antioxidant and DNA damage inhibitory activities.

Hosam M Habib1, Wissam H Ibrahim, Regine Schneider-Stock, Hassan M Hassan.   

Abstract

Lactoferrin (Lf), the main iron-binding protein of milk, has biological activities. We have evaluated the potential of camel milk lactoferrin for its ability to inhibit the proliferation of the colon cancer cell line, HCT-116, in vitro, DNA damage and its antioxidant activities for the first time. The antioxidant capacity of Lf was evaluated by different assays, including ferric-reducing/antioxidant power assay (FRAP), free radical-scavenging activity (DPPH), nitric oxide (NO) radical-scavenging assay, total antioxidant activity and DNA damage, compared with vitamin C and rutin.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23768340     DOI: 10.1016/j.foodchem.2013.03.039

Source DB:  PubMed          Journal:  Food Chem        ISSN: 0308-8146            Impact factor:   7.514


  22 in total

1.  Recombinant human lactoferrin carrying humanized glycosylation exhibits antileukemia selective cytotoxicity, microfilament disruption, cell cycle arrest, and apoptosis activities.

Authors:  Sayuri Nakamura-Bencomo; Denisse A Gutierrez; Elisa Robles-Escajeda; Blanca Iglesias-Figueroa; Tania S Siqueiros-Cendón; Edward A Espinoza-Sánchez; Sigifredo Arévalo-Gallegos; Renato J Aguilera; Quintín Rascón-Cruz; Armando Varela-Ramirez
Journal:  Invest New Drugs       Date:  2020-10-16       Impact factor: 3.850

2.  Etoposide incorporated into camel milk phospholipids liposomes shows increased activity against fibrosarcoma in a mouse model.

Authors:  Hamzah M Maswadeh; Ahmad N Aljarbou; Mohammed S Alorainy; Mansour S Alsharidah; Masood A Khan
Journal:  Biomed Res Int       Date:  2015-03-02       Impact factor: 3.411

Review 3.  Milk proteins, peptides, and oligosaccharides: effects against the 21st century disorders.

Authors:  Chia-Chien Hsieh; Blanca Hernández-Ledesma; Samuel Fernández-Tomé; Valerie Weinborn; Daniela Barile; Juliana María Leite Nobrega de Moura Bell
Journal:  Biomed Res Int       Date:  2015-02-19       Impact factor: 3.411

4.  SILAC-based proteomic profiling of the human MDA-MB-231 metastatic breast cancer cell line in response to the two antitumoral lactoferrin isoforms: the secreted lactoferrin and the intracellular delta-lactoferrin.

Authors:  Esthelle Hoedt; Karima Chaoui; Isabelle Huvent; Christophe Mariller; Bernard Monsarrat; Odile Burlet-Schiltz; Annick Pierce
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

5.  Improvement of Idiopathic Cardiomyopathy After Colon Clear.

Authors:  Randa M Nasrat; Mohammad M Nasrat; Abdullah M Nasrat; Salwa A Nasrat
Journal:  Cardiol Res       Date:  2015-04-06

Review 6.  Why whey? Camel whey protein as a new dietary approach to the management of free radicals and for the treatment of different health disorders.

Authors:  Gamal Badr; Nancy K Ramadan; Leila H Sayed; Badr M Badr; Hossam M Omar; Zeliha Selamoglu
Journal:  Iran J Basic Med Sci       Date:  2017-04       Impact factor: 2.699

Review 7.  Dairy products and colorectal cancer in middle eastern and north African countries: a systematic review.

Authors:  K El Kinany; M Deoula; Z Hatime; B Bennani; K El Rhazi
Journal:  BMC Cancer       Date:  2018-03-01       Impact factor: 4.430

Review 8.  Research Development on Anti-Microbial and Antioxidant Properties of Camel Milk and Its Role as an Anti-Cancer and Anti-Hepatitis Agent.

Authors:  Muhammad Zahoor Khan; Jianxin Xiao; Yulin Ma; Jiaying Ma; Shuai Liu; Adnan Khan; Jamal Muhammad Khan; Zhijun Cao
Journal:  Antioxidants (Basel)       Date:  2021-05-17

9.  Medicinal values of bioactive constituents of camel milk: A concise report.

Authors:  Zafar Rasheed
Journal:  Int J Health Sci (Qassim)       Date:  2017 Nov-Dec

10.  Combining different proteomic approaches to resolve complexity of the milk protein fraction of dromedary, Bactrian camels and hybrids, from different regions of Kazakhstan.

Authors:  Alma Ryskaliyeva; Céline Henry; Guy Miranda; Bernard Faye; Gaukhar Konuspayeva; Patrice Martin
Journal:  PLoS One       Date:  2018-05-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.